What it sells
Digital obesity treatment platform.
Business model breakdown
Buyer: who owns the budget?
Patients pay directly (consumer self-pay); no insurer or employer program mentioned.
Trigger: what makes them buy now?
UnverifiedObesity or overweight where weight loss with diets or GLP-1 drugs alone is not sustained.
Workflow: what inputs become what output?
Online qualification, program activation, then telemedicine with obesity physician, dietitian, psychologist and physiotherapist; blood tests every 3 months, e-prescriptions including GLP-1, app tracking, group sessions.
Economics: what it saves and how it charges
Monthly subscription; claims 1.8x more weight loss than GLP-1 drugs alone (17 kg vs 10 kg at 12 months for a 100 kg start) and 3,500+ patients.
Distribution: how it reaches customers
Direct-to-consumer online signup with promo starter kit.
Funding history and coverage
| Round date | Stage | Amount | Investors | Source |
|---|---|---|---|---|
| 2025-11-03 | — | €3M | — | news.google.com |
Profiles summarize public reporting and company websites. Business-model notes are MaxBC's reading of that material, not confirmed facts; unknowns are left blank rather than guessed. Updated 2026-10-12.